Groundbreaking Partnership: CPI Stem Cells and UFC Unite for Athlete Health

In the dynamic world of mixed martial arts (MMA), strength, agility, and resilience are paramount. Yet, even the best athletes are not immune to the wear and tear that comes with the territory. In an unprecedented move that signals a leap forward in athlete health and performance, we are happy to announce that Cellular Performance Institute (CPI) has become the Official Stem Cell Provider for Ultimate Fighting Championship (UFC), heralding a new era in regenerative medicine within sports. 

The alliance between UFC and CPI is not merely a partnership; it is a testament to the future of sports medicine and athlete care.

Stem cell therapy, long at the forefront of medical innovation, offers a beacon of hope for athletes facing injuries that conventional treatments can no longer heal. Our collaboration marks the first time a global stem cell therapy provider has joined forces with the world’s premier MMA organization, setting a precedent for health and recovery protocols in high-impact sports.

What Makes CPI Stem Cells Better?

Here are CPI we have pioneered a revolutionary approach to regenerative medicine by harnessing the power of Hypoxic Mesenchymal Stem Cells (MSCs), a game-changer not readily accessible in the United States. 

Unlike conventional stem cell therapies, which typically derive stem cells from bone marrow or fat, CPI cultivates MSCs under low-oxygen conditions, mimicking the natural environment of human tissues. This unique process enhances the survival and functionality of MSCs, significantly amplifying their efficacy in driving tissue repair and regeneration.

The CPI Difference is rooted in the exclusivity of hypoxic MSCs. This innovative approach capitalizes on the superior qualities of hypoxic MSCs, including their heightened secretion of paracrine factors, enhanced homing capabilities, and stronger immunomodulatory effects.

In our state-of-the-art laboratory, we cultivate our own Hypoxic mesenchymal stem cells (MSCs), representing a groundbreaking advancement in the field of regenerative medicine, particularly in their application for injury recovery and health optimization.
This cutting-edge approach to stem cell cultivation and therapy offers distinct advantages over traditional methods, making hypoxic MSCs a superior choice for treatments. The reasons hypoxic MSCs are considered superior can be understood through several key aspects:

1. Enhanced Survival and Functionality: MSCs cultivated under hypoxic conditions exhibit a higher survival rate when transplanted into injured or diseased tissue, translating to a greater potential for tissue repair and regeneration.

2. Increased Paracrine Factor Secretion: Hypoxic cultivation enhances the secretion of beneficial paracrine factors, amplifying the therapeutic effects of MSCs by signaling surrounding cells to initiate repair processes, modulate inflammation, and recruit additional reparative cells to the site of injury.

3. Improved Homing Capabilities: Hypoxic preconditioning enhances the homing capabilities of MSCs, ensuring more efficient migration to areas of the body requiring healing, particularly beneficial for athletes with localized injuries.

4. Enhanced Immunomodulatory Effects: Hypoxic MSCs exhibit stronger immunomodulatory effects compared to those cultured under normoxic conditions, reducing inflammation and promoting a conducive environment for healing, crucial in treating sports-related injuries.

5. Resistance to Cellular Senescence: Hypoxic conditions reduce the rate of senescence in MSCs, preserving their ability to proliferate and function over time, ensuring sustained therapeutic potential for long-term treatments and applications.

Beyond Visibility: A Shared Vision for Health

“Our partnership transcends branding opportunities. It embodies a shared commitment to athlete welfare and the pursuit of innovative health solutions.”UFC Executive Vice President and Head of Global Sponsorships, Grant Norris-Jones, expressed excitement about aligning with CPI, emphasizing the common values of health, quality of life, and injury recovery that both organizations hold dear.

Stem cell therapy represents a paradigm shift in treating sports-related injuries. Traditional approaches often involve invasive surgeries and prolonged recovery periods, leaving athletes sidelined and, at times, unable to return to their former competitive selves. CPI’s non-surgical, stem cell-based treatments offer a promising alternative, targeting the underlying issues of injuries and promoting natural healing processes.

Leading the Charge in Regenerative Medicine

At CPI, we are not just the largest manufacturer of hypoxic mesenchymal stem cells globally; we are pioneers in regenerative medicine. Our mission—to harness the transformative power of stem cells for therapeutic applications—has never been more relevant. This partnership with UFC is a milestone not only for CPI and UFC but for sports medicine as a whole. It underscores our commitment to advancing medical science and improving the lives of athletes and individuals facing debilitating conditions.

A Vision for the Future

As we embark on this journey with UFC, we are optimistic about the potential to change the landscape of sports health. Our goal is to make stem cell therapy an integral part of injury recovery and prevention, ensuring athletes have access to the most advanced, effective treatments available. The road ahead is promising, and together with UFC, we are poised to significantly impact the world of sports and beyond.

In conclusion, our partnership between UFC and CPI is more than a collaboration; it is pioneering the effort that is bringing cutting-edge medical science to the forefront of the world. As we move forward, our focus remains on enhancing the human experience through regenerative medicine and the most advanced stem cell therapy in the world.

Read the official UFC press release:

Contact Us